PRE-FUNDED COMMON STOCK PURCHASE WARRANT EIP PHARMA, INC.Notice of Exercise • July 12th, 2023 • Diffusion Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, the registered holder hereof or its permitted assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions set forth herein, at any time on or after the Issue Date, to subscribe for and purchase from EIP Pharma, Inc., a Delaware corporation (the “Company”), up to [•] shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal $0.001 (as adjusted from time to time as provided in Section 3 herein, the “Exercise Price”). This Warrant is a Pre-Funded Common Stock Purchase Warrant issued in connection with the transactions contemplated by (i) that certain Agreement and Plan of Merger, dated as of March 30, 2023, by and between Diffusion Pharmaceuticals Inc., Dawn Merger Sub Inc. and
